You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三生製藥(01530.HK)兩日回購149.35萬股 涉資1250.6萬港元
格隆匯 03-02 08:34

格隆匯3月2日丨三生製藥(01530.HK)宣佈,公司於2020年2月27日及28日,根據購回授權於聯交所分別按最高價及最低價每股8.73港元及7.89港元購回合共149.35萬股股份。就股份購回的已付總買入價為1250.5955萬港元。根據股份購回所購回的股份佔緊接股份購回前公司已發行股份總數約0.06%。

公司強調,公司的財務狀況正處於穩健水平。董事會相信,股份購回及其後註銷購回股份可提高股份價值,藉以提升公司股東的回報。此外,股份購回反映公司對其業務發展及行業的長遠前景充滿信心,且董事會相信股份購回符合公司及其股東的整體利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account